A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT00806923 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1044

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: Placebo
DRUG: bevacizumab [Avastin]
DRUG: bevacizumab [Avastin]

Sponsor

Hoffmann-La Roche